TY  - GEN
N2  - Nontuberculous mycobacteria (NTM) are ubiquitous environmental organisms that can 
cause chronic, debilitating pulmonary disease, leading to extensive parenchymal 
destruction, inflammatory lung tissue damage, airway dilation, and respiratory failure in rare cases. NTM infection disproportionately affects older individuals, post-menopausal 
women in particular, and those with chronic underlying lung diseases such as bronchiectasis, of which 80% occurs simultaneously with NTM infection. The burden of NTM disease has increased significantly in the past decade worldwide, leading to chronic, debilitating symptoms reducing quality of life and increasing morbidities, mortalities and permanent disabilities.
DO  - 10.6083/2227mq24d
DO  - DOI
AB  - Nontuberculous mycobacteria (NTM) are ubiquitous environmental organisms that can 
cause chronic, debilitating pulmonary disease, leading to extensive parenchymal 
destruction, inflammatory lung tissue damage, airway dilation, and respiratory failure in rare cases. NTM infection disproportionately affects older individuals, post-menopausal 
women in particular, and those with chronic underlying lung diseases such as bronchiectasis, of which 80% occurs simultaneously with NTM infection. The burden of NTM disease has increased significantly in the past decade worldwide, leading to chronic, debilitating symptoms reducing quality of life and increasing morbidities, mortalities and permanent disabilities.
T1  - Prescribing patterns and tolerability outcomes of multi-drug antibiotic therapy used to treat pulmonary nontuberculous mycobacterial disease due to Mycobacterium avium complex in U.S. Medicare beneficiaries with bronchiectasis
DA  - 2021
AU  - Ku, Jennifer H.
L1  - https://digitalcollections.ohsu.edu/record/9079/files/Ku.Jennifer.2021.pdf
PB  - Oregon Health and Science University
PY  - 2021
ID  - 9079
L4  - https://digitalcollections.ohsu.edu/record/9079/files/Ku.Jennifer.2021.pdf
KW  - Bronchiectasis
KW  - Anti-Bacterial Agents
KW  - Nontuberculous Mycobacteria
KW  - Mycobacterium avium Complex
KW  - therapeutic use
KW  - united states centers for medicare and medicaid services
TI  - Prescribing patterns and tolerability outcomes of multi-drug antibiotic therapy used to treat pulmonary nontuberculous mycobacterial disease due to Mycobacterium avium complex in U.S. Medicare beneficiaries with bronchiectasis
Y1  - 2021
L2  - https://digitalcollections.ohsu.edu/record/9079/files/Ku.Jennifer.2021.pdf
LK  - https://digitalcollections.ohsu.edu/record/9079/files/Ku.Jennifer.2021.pdf
UR  - https://digitalcollections.ohsu.edu/record/9079/files/Ku.Jennifer.2021.pdf
ER  -